Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis

Development of a gene delivery system with high efficiency and a good safety profile is essential for successful gene therapy. Here we developed a targeted non-viral delivery system using a multifunctional lipid ECO for treating Leber’s congenital amaurosis type 2 (LCA2) and tested this in a mouse m...

Full description

Bibliographic Details
Main Authors: Da Sun, Bhubanananda Sahu, Songqi Gao, Rebecca M. Schur, Amita M. Vaidya, Akiko Maeda, Krzysztof Palczewski, Zheng-Rong Lu
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117301324
_version_ 1819066448019980288
author Da Sun
Bhubanananda Sahu
Songqi Gao
Rebecca M. Schur
Amita M. Vaidya
Akiko Maeda
Krzysztof Palczewski
Zheng-Rong Lu
author_facet Da Sun
Bhubanananda Sahu
Songqi Gao
Rebecca M. Schur
Amita M. Vaidya
Akiko Maeda
Krzysztof Palczewski
Zheng-Rong Lu
author_sort Da Sun
collection DOAJ
description Development of a gene delivery system with high efficiency and a good safety profile is essential for successful gene therapy. Here we developed a targeted non-viral delivery system using a multifunctional lipid ECO for treating Leber’s congenital amaurosis type 2 (LCA2) and tested this in a mouse model. ECO formed stable nanoparticles with plasmid DNA (pDNA) at a low amine to phosphate (N/P) ratio and mediated high gene transfection efficiency in ARPE-19 cells because of their intrinsic properties of pH-sensitive amphiphilic endosomal escape and reductive cytosolic release (PERC). All-trans-retinylamine, which binds to interphotoreceptor retinoid-binding protein (IRBP), was incorporated into the nanoparticles via a polyethylene glycol (PEG) spacer for targeted delivery of pDNA into the retinal pigmented epithelium. The targeted ECO/pDNA nanoparticles provided high GFP expression in the RPE of 1-month-old Rpe65−/− mice after subretinal injection. Such mice also exhibited a significant increase in electroretinographic activity, and this therapeutic effect continued for at least 120 days. A safety study in wild-type BALB/c mice indicated no irreversible retinal damage following subretinal injection of these targeted nanoparticles. All-trans-retinylamine-modified ECO/pDNA nanoparticles provide a promising non-viral platform for safe and effective treatment of RPE-specific monogenic eye diseases such as LCA2.
first_indexed 2024-12-21T16:02:31Z
format Article
id doaj.art-83fc4a4df7e748068a175bb78bcf769e
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-21T16:02:31Z
publishDate 2017-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-83fc4a4df7e748068a175bb78bcf769e2022-12-21T18:57:57ZengElsevierMolecular Therapy: Nucleic Acids2162-25312017-06-017C425210.1016/j.omtn.2017.02.005Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital AmaurosisDa Sun0Bhubanananda Sahu1Songqi Gao2Rebecca M. Schur3Amita M. Vaidya4Akiko Maeda5Krzysztof Palczewski6Zheng-Rong Lu7Case Center for Biomolecular Engineering and Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USADepartment of Ophthalmology and Visual Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USADepartment of Pharmacology and Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, OH 44140, USACase Center for Biomolecular Engineering and Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USACase Center for Biomolecular Engineering and Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USADepartment of Ophthalmology and Visual Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USADepartment of Pharmacology and Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, OH 44140, USACase Center for Biomolecular Engineering and Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USADevelopment of a gene delivery system with high efficiency and a good safety profile is essential for successful gene therapy. Here we developed a targeted non-viral delivery system using a multifunctional lipid ECO for treating Leber’s congenital amaurosis type 2 (LCA2) and tested this in a mouse model. ECO formed stable nanoparticles with plasmid DNA (pDNA) at a low amine to phosphate (N/P) ratio and mediated high gene transfection efficiency in ARPE-19 cells because of their intrinsic properties of pH-sensitive amphiphilic endosomal escape and reductive cytosolic release (PERC). All-trans-retinylamine, which binds to interphotoreceptor retinoid-binding protein (IRBP), was incorporated into the nanoparticles via a polyethylene glycol (PEG) spacer for targeted delivery of pDNA into the retinal pigmented epithelium. The targeted ECO/pDNA nanoparticles provided high GFP expression in the RPE of 1-month-old Rpe65−/− mice after subretinal injection. Such mice also exhibited a significant increase in electroretinographic activity, and this therapeutic effect continued for at least 120 days. A safety study in wild-type BALB/c mice indicated no irreversible retinal damage following subretinal injection of these targeted nanoparticles. All-trans-retinylamine-modified ECO/pDNA nanoparticles provide a promising non-viral platform for safe and effective treatment of RPE-specific monogenic eye diseases such as LCA2.http://www.sciencedirect.com/science/article/pii/S2162253117301324Non-viral gene deliverymultifunctional lipidgene replacement therapyLeber’s congenital amaurosisRPE65 protein
spellingShingle Da Sun
Bhubanananda Sahu
Songqi Gao
Rebecca M. Schur
Amita M. Vaidya
Akiko Maeda
Krzysztof Palczewski
Zheng-Rong Lu
Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
Molecular Therapy: Nucleic Acids
Non-viral gene delivery
multifunctional lipid
gene replacement therapy
Leber’s congenital amaurosis
RPE65 protein
title Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
title_full Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
title_fullStr Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
title_full_unstemmed Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
title_short Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
title_sort targeted multifunctional lipid eco plasmid dna nanoparticles as efficient non viral gene therapy for leber s congenital amaurosis
topic Non-viral gene delivery
multifunctional lipid
gene replacement therapy
Leber’s congenital amaurosis
RPE65 protein
url http://www.sciencedirect.com/science/article/pii/S2162253117301324
work_keys_str_mv AT dasun targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT bhubananandasahu targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT songqigao targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT rebeccamschur targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT amitamvaidya targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT akikomaeda targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT krzysztofpalczewski targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis
AT zhengronglu targetedmultifunctionallipidecoplasmiddnananoparticlesasefficientnonviralgenetherapyforleberscongenitalamaurosis